Page last updated: 2024-10-22

albuterol and Sleep Apnea Syndromes

albuterol has been researched along with Sleep Apnea Syndromes in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Sleep Apnea Syndromes: Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rasche, K1
Duchna, HW1
Orth, M1
Bauer, TT1
Lauer, J1
Podbregar, D1
Schultze-Werninghaus, G1

Trials

1 trial available for albuterol and Sleep Apnea Syndromes

ArticleYear
[Effect of salmeterol in obstructive sleep apnea syndrome].
    Pneumologie (Stuttgart, Germany), 1998, Volume: 52, Issue:1

    Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-

1998